FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology, and aims at treating patients after phacoemulsification of age-related cataract. After phacoemulsification of age-related cataract, in addition to standard application of antibiotic solution to patient in conjunctival cavity of operated eye for 30 days 2 times day for 1 drop of combined preparation is installed, consisting of 6.0 ml of tear substitute based on 0.15 % sodium salt of hyaluronic acid, 3.0 ml of 0.1 % dexamethasone and 1.0 ml of 0.25 % Derinat.
EFFECT: use of the invention provides preventing postoperative induced damage of eye surface structures and dry eye syndrome after phacoemulsification, improved local immune status of the operated eye, reduced number of instillations and ease of use for the patient.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING RECURRENT EROSION OF CORNEAS OF VARIOUS ORIGINS | 2019 |
|
RU2716429C1 |
| METHOD FOR PREDICTING DEVELOPMENT OF DRY EYE SYNDROME FOLLOWING PHACOEMULSIFICATION OF AGE-RELATED CATARACT | 2020 |
|
RU2728971C1 |
| METHOD OF TREATING PERIPHERAL ULCERATIVE KERATITIS ACCOMPANYING SJOGREN'S SYNDROME ASSOCIATED WITH RHEUMATOID ARTHRITIS | 2015 |
|
RU2585611C1 |
| METHOD FOR TREATMENT OF HEAVY FORMS OF DRY KERATOCONJUNCTIVITIS | 2016 |
|
RU2621553C1 |
| EYE OINTMENT BASED ON 6-METHYL-3-(THIETAN-3-YL)URACIL WITH WOUND-HEALING EFFECT | 2019 |
|
RU2705392C1 |
| GEL-LIKE ARTIFICIAL TEARS WITH ANTISEPTIC AND REPARATIVE ACTION | 2018 |
|
RU2679319C1 |
| METHOD OF TREATING BLEPHAROCONJUNCTIVAL FORM OF DRY EYE SYNDROME | 2012 |
|
RU2510701C1 |
| METHOD OF TREATING POSTOPERATIVE CORNEAL OEDEMA IN AGE-RELATED CATARACT SURGERY | 2011 |
|
RU2476194C1 |
| DIAGNOSTIC TECHNIQUE AND METHOD OF THERAPY OF DRUG-INDUCED DRY EYE SYNDROME | 2014 |
|
RU2554818C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING CORNEAL EDEMAS | 2001 |
|
RU2197923C1 |
